85 related articles for article (PubMed ID: 4411685)
1. A new antigen in leukemia L1210 subline (resistant to methylglyoxal-bis-guanylhydrazone).
Kitano M
Bull Chest Dis Res Inst Kyoto Univ; 1974 Mar; 7(2):126-34. PubMed ID: 4411685
[No Abstract] [Full Text] [Related]
2. Antigenic differences between leukemia L1210 and a subline resistant to methylglyoxal-bis(guanylhydrazone).
Kitano M; Mihich E; Pressman D
Cancer Res; 1972 Feb; 32(2):181-6. PubMed ID: 5061638
[No Abstract] [Full Text] [Related]
3. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylglyoxal-bis(guanylhydrazone) on polyamine metabolism in spleens of mice with disseminated L1210 lymphoid leukemia.
Heby O; Russell DH
Cancer Res; 1974 Apr; 34(4):886-92. PubMed ID: 4815000
[No Abstract] [Full Text] [Related]
5. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of ornithine decarboxylase activity and inhibition of S-adenosyl-L-methionine decarboxylase activity in leukaemic mice by methylglyoxal bis(guanylhydrazone).
Heby O; Sauter S; Russell DH
Biochem J; 1973 Dec; 136(4):1121-4. PubMed ID: 4786532
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances.
Corti A; Dave C; Williams-Ashman HG; Mihich E; Schenone A
Biochem J; 1974 May; 139(2):351-7. PubMed ID: 4447616
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
Strzadala L; Opolski A; Radzikowski C; Mihich E
Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
[TBL] [Abstract][Full Text] [Related]
9. Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.
Fuji H; Mihich E; Pressman D
J Immunol; 1977 Sep; 119(3):983-6. PubMed ID: 330761
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA synthesis by methylglyoxal bis(guanylhydrazone) during lymphocyte transformation.
Otani S; Mizoguchi Y; Matsui I; Morisawa S
Mol Biol Rep; 1974 Dec; 1(8):431-6. PubMed ID: 4453330
[No Abstract] [Full Text] [Related]
11. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the inhibition of DNA biosynthesis by 4,4'-diacetyldiphenylurea-bis(guanylhydrazone) in leukemia L1210 cells.
Dave C; Ehrke J; Mihich E
Cancer Res; 1973 Sep; 33(9):2129-34. PubMed ID: 4737638
[No Abstract] [Full Text] [Related]
14. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical enhancement of S-adenosylmethionine decarboxylase in rat tissues following administration of the specific inhibitor methyl glyoxal bis(guanylhydrazone).
Pegg AE; Corti A; Williams-Ashman HG
Biochem Biophys Res Commun; 1973 May; 52(2):696-701. PubMed ID: 4711181
[No Abstract] [Full Text] [Related]
16. Effect of methylglyoxal bis(guanylhydrazone) on S-adenosylmethionine decarboxylase in the isolated perfused rat.
Pegg AE; Jefferson LS
FEBS Lett; 1974 Apr; 40(2):321-4. PubMed ID: 4851665
[No Abstract] [Full Text] [Related]
17. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
Mihich E; Kitano M
Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297
[No Abstract] [Full Text] [Related]
18. Antigenicity of L1210 leukemic sublines induced by drugs.
Nicolin A; Vadlamudi S; Goldin A
Cancer Res; 1972 Apr; 32(4):653-7. PubMed ID: 5014777
[No Abstract] [Full Text] [Related]
19. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia.
Sunkara PS; Prakash NJ; Chang CC; Sjoerdsma A
J Natl Cancer Inst; 1983 Mar; 70(3):505-9. PubMed ID: 6403743
[No Abstract] [Full Text] [Related]
20. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
Goncharova SA; Minenkova EA; Fomina MM; Demidova NS
Eksp Onkol; 1984; 6(4):38-41. PubMed ID: 6499750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
